{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:37:59Z","timestamp":1778621879137,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"37-38","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.vaccine.2007.06.061","type":"journal-article","created":{"date-parts":[[2007,7,21]],"date-time":"2007-07-21T11:23:52Z","timestamp":1185017032000},"page":"6744-6754","source":"Crossref","is-referenced-by-count":23,"title":["A combined DNA vaccine enhances protective immunity against Mycobacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector"],"prefix":"10.1016","volume":"25","author":[{"given":"Da-Hai","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Dan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.06.061_bib1","unstructured":"Global Tuberculosis Control, Surveillance, Planning, Financing. Report WHO. Geneva: WHO; 2006, p. 1\u2013242."},{"issue":"22","key":"10.1016\/j.vaccine.2007.06.061_bib2","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMra050570","article-title":"Brucellosis","volume":"352","author":"Pappas","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2007.06.061_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/vetres:2003037","article-title":"Rough vaccines in animal brucellosis: structural and genetic basis and present status","volume":"35","author":"Moriyon","year":"2004","journal-title":"Vet Res"},{"issue":"2","key":"10.1016\/j.vaccine.2007.06.061_bib4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","article-title":"DNA vaccines: progress and challenges","volume":"175","author":"Donnelly","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.06.061_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrmicro1419","article-title":"Advances in tuberculosis vaccine strategies","volume":"4","author":"Skeiky","year":"2006","journal-title":"Nat Rev Microbiol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2007.06.061_bib6","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0264-410X(97)00140-0","article-title":"Nucleic acid vaccination of Brucella abortus ribosomal L7\/L12 gene elicits immune response","volume":"15","author":"Kurar","year":"1997","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.06.061_bib7","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/IAI.72.4.2081-2087.2004","article-title":"Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells","volume":"72","author":"Munoz-Montesino","year":"2004","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2007.06.061_bib8","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1128\/IAI.69.8.4816-4822.2001","article-title":"Protection of BALB\/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant","volume":"69","author":"Al-Mariri","year":"2001","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2007.06.061_bib9","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/IAI.70.5.2507-2511.2002","article-title":"A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB\/c mice","volume":"70","author":"Velikovsky","year":"2002","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2007.06.061_bib10","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","article-title":"Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2007.06.061_bib11","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/IAI.73.10.6537-6546.2005","article-title":"A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.06.061_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-1119(88)90540-9","article-title":"The cloning, expression and nucleotide sequence of a gene coding for an immunogenic Brucella abortus protein","volume":"63","author":"Mayfield","year":"1988","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2007.06.061_bib13","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1016\/j.vaccine.2005.03.025","article-title":"Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection","volume":"23","author":"Cai","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.06.061_bib14","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/IAI.67.4.1702-1707.1999","article-title":"Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis","volume":"67","author":"Kamath","year":"1999","journal-title":"Infect Immun"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2007.06.061_bib15","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1016\/S0264-410X(03)00378-5","article-title":"Comparative analysis of effects of cytokine gene adjuvants on DNA vaccination against Mycobacterium tuberculosis heat shock protein 65","volume":"21","author":"Baek","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.06.061_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1440-1711.2002.01087.x","article-title":"Comparative affects of plasmid-encoded interleukin 12 and interleukin 18 on the protective efficacy of DNA vaccination against Mycobacterium tuberculosis","volume":"80","author":"Triccas","year":"2002","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.06.061_bib17","first-page":"491","article-title":"Effect of exogenous interleukin-18 (IL-18) and IL-12 in the course of Brucella abortus 2308 infection in mice","volume":"9","author":"Pasquali","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"32","key":"10.1016\/j.vaccine.2007.06.061_bib18","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1016\/j.vaccine.2005.03.024","article-title":"Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice","volume":"23","author":"Cai","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.06.061_bib19","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/IAI.70.4.1949-1956.2002","article-title":"Coexpression of interleukin-12 chains by a self-splicing vector increases the protective cellular immune response of DNA and Mycobacterium bovis BCG vaccines against Mycobacterium tuberculosis","volume":"70","author":"Palendira","year":"2002","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2007.06.061_bib20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1089\/1044549041474742","article-title":"Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis","volume":"23","author":"Cai","year":"2004","journal-title":"DNA Cell Biol"},{"issue":"20","key":"10.1016\/j.vaccine.2007.06.061_bib21","first-page":"1410","article-title":"Immunogenicity and protection of divalent DNA vaccine encoding antigens MPT83 and MPT64 of Mycobacterium tuberculosis","volume":"85","author":"Tian","year":"2005","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.vaccine.2007.06.061_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1479-5876-1-14","article-title":"The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity","volume":"1","author":"Shafer-Weaver","year":"2003","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.vaccine.2007.06.061_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1574-6968.1994.tb07123.x","article-title":"The Brucella abortus vaccine strain B19 carries a deletion in the erythritol catabolic genes","volume":"121","author":"Sangari","year":"1994","journal-title":"FEMS Microbiol Lett"},{"issue":"1","key":"10.1016\/j.vaccine.2007.06.061_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1096\/fasebj.5.1.1991594","article-title":"Immunogold labeling of perforin and serine esterases in granulated metrial gland cells","volume":"5","author":"Zheng","year":"1991","journal-title":"FASEB J"},{"issue":"10","key":"10.1016\/j.vaccine.2007.06.061_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/dna.2005.24.605","article-title":"Coadministration of interleukin 2 plasmid DNA with combined DNA vaccines significantly enhances the protective efficacy against Mycobacterium tuberculosis","volume":"24","author":"Cai","year":"2005","journal-title":"DNA Cell Biol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.06.061_bib26","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1073\/pnas.94.10.5243","article-title":"Identification of nitric oxide synthase as a protective locus against tuberculosis","volume":"94","author":"MacMicking","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2007.06.061_bib27","first-page":"71","article-title":"Combined recombinant DNA vaccine results in significant protection against Mycobacterium tuberculosis","volume":"35","author":"Pan","year":"2003","journal-title":"Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)"},{"issue":"8","key":"10.1016\/j.vaccine.2007.06.061_bib28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1089\/dna.2006.25.438","article-title":"A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge","volume":"25","author":"Cai","year":"2006","journal-title":"DNA Cell Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.06.061_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/dna.2006.0552","article-title":"A combined DNA vaccine encoding BCSP31, SOD, and L7\/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses","volume":"26","author":"Yu","year":"2007","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.vaccine.2007.06.061_bib30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application, and optimization","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.06.061_bib31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/IAI.74.1.557-565.2006","article-title":"Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection","volume":"74","author":"Wozniak","year":"2006","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.06.061_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.0105-2896.2004.00150.x","article-title":"Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants","volume":"199","author":"Calarota","year":"2004","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2007.06.061_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.186.1.39","article-title":"Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis","volume":"186","author":"Cooper","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.06.061_bib34","article-title":"DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation","author":"Yoshida","year":"2005","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2007.06.061_bib35","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.vaccine.2005.09.025","article-title":"The immunogenicity and protective efficacy of Mtb8.4\/hIL-12 chimeric gene vaccine","volume":"24","author":"Li","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.06.061_bib36","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2007.06.061_bib37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ni1102-1033","article-title":"Immune Defence: microbial interference","volume":"3","author":"Hornef","year":"2002","journal-title":"Nat Immunol"},{"issue":"18","key":"10.1016\/j.vaccine.2007.06.061_bib38","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1101\/gad.909001","article-title":"NF-\u03baB signaling pathways in mammalian and insect innate immunity","volume":"15","author":"Silverman","year":"2001","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/j.vaccine.2007.06.061_bib39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4049\/jimmunol.175.1.441","article-title":"DNA augments antigenicity of mycobacterial dna-binding protein 1 and confers protection against Mycobacterium tuberculosis infection in mice","volume":"175","author":"Matsumoto","year":"2005","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07007633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07007633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T08:40:03Z","timestamp":1587804003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07007633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":39,"journal-issue":{"issue":"37-38","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0264410X07007633"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.06.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}